Company Monitoring Page for Merck

latest headlines for company on cafepharma

Merck to gain rights to Mochida diabetes drug
Reuters
Tue, 12/13/11 - 08:09 am
Tags:
Merck, diabetes, Mochida
Bristol-Myers Presents Data
Yahoo/Zacks
Sat, 12/10/11 - 12:56 pm
Tags:
Bristol-Myers Squibb, AstraZeneca, diabetes, Dapagliflozin, glimepiride, Merck, NovoNordisk
Diabetes Meds, Pancreatitis & Prescribing Habits
Pharmalot
Fri, 12/9/11 - 11:26 am
Tags:
diabetes, pancreatitis, physicians, Byetta, Amylin, Januvia, Merck
Merck Asked by U.K. Agency for More Tests of Smoker’s Cough Drug
Bloomberg
Thu, 12/8/11 - 11:23 am
Tags:
smoker's cough, Merck, UK, NICE, Daxas
6 Buffett-Friendly Pharmaceutical Stocks
Seeking Alpha
Thu, 12/8/11 - 11:19 am
Tags:
Abbott Laboratories, Warren Buffett, Eli Lilly, Merck, Pfizer, Teva Pharmaceuticals, Bristol-Myers Squibb
Dendreon to sell royalty in Merck hep C drug
Reuters
Tue, 12/6/11 - 04:30 pm
Tags:
Merck, Dendreon, hepatitis C, Victrelis
A Trading Strategy For 7 Biotech/Healthcare Stocks With Upcoming PDUFA Date
Seeking Alpha
Tue, 12/6/11 - 09:21 am
Tags:
Alkermes, Amylin, Antares, AstraZeneca, Bristol-Myers Squibb, Merck, Eli Lilly
Merck to Invest $1.5 Billion on Research in China Over 5 Years
Bloomberg
Tue, 12/6/11 - 09:20 am
Tags:
Merck, R&D, China
GenericsWeb Analyses Generic Opportunities for Merck’s Blockbuster Ezetimibe
PR NewsWire
Sat, 12/3/11 - 04:09 pm
Tags:
Merck, Ezetimibe, cholesterol
Why Large Cap Healthcare Multiples Should Expand
Seeking Alpha
Thu, 12/1/11 - 12:10 pm
Tags:
Abbott Laboratories, Gilead, JNJ, Merck, Medtronic, Medicis, Pfizer
Pfizer and Merck May Benefit From Spinoffs, Goldman Sachs Says
Bloomberg
Wed, 11/30/11 - 02:10 pm
Tags:
Pfizer, Merck, spinoff
Why the Street Should Love Merck's Earnings
Motley Fool
Wed, 11/30/11 - 11:51 am
Tags:
Merck, earnings
Winners and Losers of Roche's Avastin Woes
Motley Fool
Tue, 11/29/11 - 06:48 pm
Tags:
Roche, Avastin, breast cancer, Merck, GSK, Bristol-Myers Squibb, Eli Lilly, Teva Pharmaceuticals, Dr Reddy's, Watson, Seattle Genetics
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Tags:
Amarin, AMR101, Ironwood, linaclotide, Merck, Ariad, ridaforolimus, Vivus, Qnexa, Avanafil, Amgen, Xgeva, Cell Therapeutics, pixantrone, Kalydeco, Vertex, ONYX Pharmaceuticals, Carfilzomib, Pfizer, Bristol-Myers Squibb, Eliquis, Chelsea Therapeutics, Northera, Levadex, MAP Pharmaceuticals, Roche, Curis, vismodegib, Biogen Idec, Elan, Tysabri, Amylin, Bydureon, Dapagliflozin, Uplypso, Protalix BioTherapeutics, Teva Pharmaceuticals, BioSante, Bio-T-Gel, Corlux, Corcept Therapeutics, Discovery Labs, Surfaxin
Facebook apologizes for Merck homepage mix-up
Reuters
Mon, 11/28/11 - 04:42 pm
Tags:
Facebook, Merck, social media, Merck KGaA
Vertex: competition fears hit hard
FT.com
Mon, 11/28/11 - 09:53 am
Tags:
Incivek, Merck, JNJ, Vertex
Merck chairman to retire this week
Bizjournals.com
Mon, 11/28/11 - 09:50 am
Tags:
Merck, Richard Clark
Has Merck Become the Perfect Stock?
Motley Fool
Sat, 11/26/11 - 10:40 am
Tags:
Merck
UK switches over to Merck, Sanofi HPV vaccine
Reuters
Sat, 11/26/11 - 10:31 am
Tags:
Merck, Sanofi, HPV, Gardasil, Cervarix, GSK
Bayer YAZ To Follow Merck's Vioxx?
Injuryboard.com
Wed, 11/23/11 - 01:25 pm
Tags:
Merck, Yaz, Yasmin, Vioxx

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.